Table 2.
Comparison of disease activity parameters and status according to SLEDAI-2K definition of articular involvement (Group 1—patients with joint involvement defined by SLEDAI-2K, Group 2—patients without joint involvement defined by SLEDAI-2K).
| Group 1 (N = 21) |
Group 2 (N = 48) |
P | |
|---|---|---|---|
| SLEDAI-2K (mean ± SD) | 4.9 ± 1.3 | 1.5 ± 2.2 | 0.0001 |
| Tender joint count (mean ± SD) |
9.1 ± 5.0 | 3.6 ± 4.4 | 0.0001 |
| Swollen joint count (mean ± SD) |
4.6 ± 2.3 | 0.3 ± 0.6 | 0.0001 |
| GH (mean ± SD) | 58.0 ± 29.1 | 39.7 ± 22.8 | 0.01 |
| ESR (mm/h, mean ± SD) | 43.2 ± 32.8 | 23.2 ± 17.7 | 0.01 |
| DAS28 (mean ± SD) | 5.3 ± 1.2 | 3.5 ± 1.1 | NS |
| DAS28 remission (N/%) | 0/0 | 8/16.7 | NS |
| DAS28 low disease activity (N/%) | 1/4.7 | 21/43.7 | 0.001 |
| DAS28 moderate disease activity (N/%) | 6/28.6 | 23/47.9 | NS |
| DAS28 high disease activity (N/%) | 14/66.6 | 4/8.4 | 0.0001 |